In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

If you started off the year eager and excited to create a healthier you but haven't seen the results you want, you're not ...

On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its ...

However, those who added a teaspoon of sugar to their brew saw a four-year weight ... over four years. However, those who increased their daily coffee intake by adding just one teaspoon of sugar ...

Strategy co-founder Michael Saylor posted the Bitcoin (BTC) chart typically posted ... software business — a 3% year-over-year decrease — and a $640 million loss for the quarter.

but studies have found that it leads to even greater weight loss – over 20% in the case of Mounjaro; as against 14% for Ozempic. From the 17th of February this year, Mounjaro will be licenced ...

As we step into 2025, investors find themselves reflecting on a market narrative that seemed almost scripted. Read more here.

After going through early menopause in her 40s, Michelle Kloese lost 50 pounds by walking, strength training, drinking water, ...

When I went to the hospital last year for my annual mammogram, I expected to be in and out in 60 minutes. Being a healthy ...

Another seasonal trend is the four-year U.S. presidential cycle. In general, the market rises modestly in the first year after a presidential election, followed by trouble in the second year. In years ...

Real-time index price for TSX Financials Capped Index (TTFS), along with buy or sell indicators, analysis, charts, historical performance, news and more ...